Cargando…
LIPid Intensive Drug therapy for Sepsis Pilot (LIPIDS-P): Phase I/II clinical trial protocol of lipid emulsion therapy for stabilising cholesterol levels in sepsis and septic shock
INTRODUCTION: Sepsis is a life-threatening, dysregulated response to infection. Both high-density lipoprotein and low-density lipoprotein cholesterol should protect against sepsis by several mechanisms; however, for partially unknown reasons, cholesterol levels become critically low in patients with...
Autores principales: | Guirgis, Faheem W, Black, Lauren Page, Rosenthal, Martin Daniel, Henson, Morgan, Ferreira, Jason, Leeuwenburgh, Christiaan, Kalynych, Colleen, Moldawer, Lyle L, Miller, Taylor, Jones, Lisa, Crandall, Marie, Reddy, Srinivasa T, Wu, Samuel S, Moore, Frederick A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756323/ https://www.ncbi.nlm.nih.gov/pubmed/31537565 http://dx.doi.org/10.1136/bmjopen-2019-029348 |
Ejemplares similares
-
Lipid intensive drug therapy for sepsis pilot: A Bayesian phase I clinical trial
por: Guirgis, Faheem W., et al.
Publicado: (2020) -
Lipid and Lipoprotein Dysregulation in Sepsis: Clinical and Mechanistic Insights into Chronic Critical Illness
por: Barker, Grant, et al.
Publicado: (2021) -
Lipid and lipoprotein predictors of functional outcomes and long-term mortality after surgical sepsis
por: Guirgis, Faheem W., et al.
Publicado: (2021) -
HDL inflammatory index correlates with and predicts severity of organ failure in patients with sepsis and septic shock
por: Guirgis, Faheem W., et al.
Publicado: (2018) -
Sepsis and Critical Illness Research Center investigators: protocols and standard operating procedures for a prospective cohort study of sepsis in critically ill surgical patients
por: Loftus, Tyler J, et al.
Publicado: (2017)